MOPEAD at CTAD conference in Boston

Discussions took place on Pre-screening Initiatives to Identify Individuals with Preclinical or Early Alzheimer’s disease for Clinical Trials.

Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations